EP300 and lymphoma: Epigenetic dysfunction, such as gain-of-function mutations of EZH2 and loss-of-function mutations of CREBP and EP300, disrupts the normal biological link between lymphoma cells and immune TME, and motivates immune evasion in GCB lymphoma.